Comparing a Suture-based System for the Removal of Arterial and Veinous ECMO Cannulas to the Standard Approach

NCT07019662 · tracked via the Priya Life Science Germany tracker

Sponsor

IHF GmbH - Institut für Herzinfarktforschung

Phase

Not applicable

Started

2025-10-27

Last updated

2026-04-16

Condition(s) studied

VA-ECMO

Investigational drug(s) / intervention(s)

Decannulation with a medical deviceDecannulation using surgical removal or manual compression

Decannulation with a medical device: Wound Closure with a medical device

Decannulation using surgical removal or manual compression: Wound closure using surgical removal or manual compression

Study summary

Background:

Patients with severe heart and lung failure may be treated with VA-ECMO (veno-arterial extracorporeal membrane oxygenation), a life-support machine that temporarily takes over the function of the heart and lungs. To connect the patient to ECMO, large tubes (cannulas) are inserted into major blood vessels in the groin area.

When the patient no longer needs ECMO, these cannulas must be removed - a process known as decannulation. Closing the artery after removing the cannula is a critical step and can be associated with complications such as bleeding, vessel injury, or blood clots.

Currently, there are different methods to close the artery:

* Surgical closure: open surgery to directly suture the artery
* Manual compression: pressing on the artery to stop bleeding
* Vascular closure devices (VCDs): special tools that close the artery through the skin

There is no clear standard yet on which method is safest and most effective for ECMO patients.

Purpose of the Study:

The study aims to determine whether using a vascular closure device is as safe and effective as the current standard methods for femoral artery closure after VA-ECMO.

Study Design:

This is a randomized controlled trial. Patients who are scheduled for decannulation after VA-ECMO support will be randomly assigned to one of two groups:

* Intervention Group: Patients receive a vascular closure device to seal the artery (Abbott Perclose™ ProStyle™ Suture-Mediated Closure System).
* Control Group: Patients receive standard care, which may be either:

* Manual compression, or
* Surgical closure, depending on the treating physician's judgment and the patient's condition.

This allows for a real-world comparison of the Closure Device method to current clinical practice.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Age ≥ 18 Years * Femoral placement of VA-ECMO with peripheral, percutaneous cannulation * Arterial puncture site above the femoral bifurcation * Cannula size must match or be smaller than the maximally licensed diameter for Perclose™ ProStyle™ (26 F (French) outer diameter arterial and 29 F outer diameter veinous) * Patients must be eligible for either the Perclose™ ProStyle™ device or one of the two guideline-compliant alternatives for ECMO cannula removal (manual compression or surgical closure) according to the investigator's judgment. * Initial arterial and/or venous puncture for ECMO cannulation was performed using ultrasound guidance with corresponding documentation available in the patient record. Exclusion Criteria: * Severe calcification * Surgical cannulation * Ongoing Infection of the ECMO site * Any patient who does not fullfil the eligibility criteria for the use of the study device according to its current Instructions for Use (IFU), including known contraindications, limitations or warnings. * Participation in another interventional clinical trial. * Patients who are pregnant (assessed by clinical routine testing) or lactating.

Primary outcome measure(s)

Incidence of a combined vessel-orientated clinical endpoint (VOCE) — within 48 hours post ECMO removal

Trial sites (2)

Facility	City	Region	Status
Universitäres Herz- und Gefäßzentrum Frankfurt ZIM - Med. Clinic 3 - Cardiology and Angiology	Frankfurt	Germany	Recruiting
Universitätsmedizin der Johannes Gutenberg-Universität Mainz - Zentrum für Kardiologie	Mainz	Germany	Recruiting

More IHF GmbH - Institut für Herzinfarktforschung trials in Germany

accuRate Evaluation of Benefit With Optimal Medical Treatment With or Without Transcatheter Valve Repair of PARADOXical Low Flow Low Gradient Aortic Stenosis Active, not recruiting

Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes Active, not recruiting

BENTO - Bronchoscopic Lung Volume Reduction in Severe Emphysema Using Thermoablation Recruiting

Trial to Assess Non-inferiority of an Orbital Atherectomy Only Versus a Calcium-tailored Debulking Approach Recruiting

ILUMIEN-V - AERO: All-comEr Registry of OCT (AERO) Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07019662 on ClinicalTrials.gov ↗ ← All trials in Germany